Average Co-Inventor Count = 5.89
ph-index = 12
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Blueprint Medicines Corporation (13 from 60 patents)
2. Amgen Inc. (8 from 1,970 patents)
3. D.e. Shaw Research, LLC (2 from 27 patents)
4. Relay Therapeutics, Inc. (2 from 12 patents)
5. Other (1 from 832,680 patents)
24 patents:
1. 11629145 - SHP2 phosphatase inhibitors and methods of use thereof
2. 11591336 - Substituted pyrazolo[3,4-b]pyrazines as SHP2 phosphatase inhibitors
3. 11279688 - Inhibitors of RET
4. 10875837 - Inhibitors of the fibroblast growth factor receptor
5. 10774070 - 2-(pyridin-3-yl)-pyrimidine derivatives as RET inhibitors
6. 10584114 - Inhibitors of RET
7. 10227329 - Compounds useful for treating disorders related to RET
8. 10221154 - Inhibitors of the fibroblast growth factor receptor
9. 10202365 - 2-(pyridin-3-yl)-pyrimidine derivatives as RET inhibitors
10. 10035789 - Compounds useful for treating disorders related to RET
11. 10030005 - Inhibitors of RET
12. 10000490 - Inhibitors of the fibroblast growth factor receptor
13. 9994552 - Compositions useful for treating disorders related to kit
14. 9695165 - Inhibitors of the fibroblast growth factor receptor
15. 9499522 - Compositions useful for treating disorders related to kit